- Illustrations
- Pregnancy & Fetal Development
- Fetus at Week 33 - Asian Skin
Fetus at Week 33 - Asian Skin
A 3D illustration of a fetus at week 33 in an alternative pose on a white background with placenta and umbilical cord. Asian skin tone.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Fetus at 33 weeks’ gestation appears in a third-trimester posture with the head flexed toward the thorax and the hips and knees held in flexion, consistent with reduced intrauterine space. Placenta lies adjacent to the fetal body with the umbilical cord arising from the chorionic plate and coursing toward the fetal umbilicus, where it would normally enter at the anterior abdominal wall in the midline. Limbs show clearer segmental proportions, and the hands and feet sit close to the trunk, with distal digits and nail plates readily appreciable at this age. Asian skin tone is applied consistently across the fetal integument. Week 33 anatomy matters when counseling about late preterm delivery and when teaching how fetal and placental findings relate to surveillance in the third trimester, including growth restriction, oligohydramnios, and placental insufficiency. The inclusion of placenta and cord supports discussion of cord length, cord coiling, and insertion patterns that can complicate pregnancy, such as marginal insertion or velamentous insertion with associated fetal heart rate decelerations during labor. A white, uncluttered background keeps attention on fetal proportions, flexion posture, and fetoplacental relationships rather than maternal tissues. Use this illustration in embryology and obstetrics curricula, NICU orientation materials addressing late-preterm risks, and publisher graphics for chapters on third-trimester development and placental anatomy. It also fits patient-facing prenatal education where inclusive skin tone representation supports culturally sensitive counseling. Anatomical accuracy verified by SciePro's Medical Advisory Board.